Cargando…
“High-Risk Breast Cancer Screening in BRCA1/2 Carriers Leads to Early Detection and Improved Survival After a Breast Cancer Diagnosis”
BACKGROUND: Germline BRCA1/2 pathogenic variant (PV) carriers have high lifetime risk of developing breast cancer and therefore subjected to intense lifetime screening. However, solid data on the effectiveness of high-risk screening of the BRCA1/2 carrier population is limited. PATIENTS AND METHODS:...
Autores principales: | Shraga, Shay, Grinshpun, Albert, Zick, Aviad, Kadouri, Luna, Cohen, Yogev, Maimon, Ofra, Adler-Levy, Yael, Zeltzer, Galina, Granit, Avital, Maly, Bella, Carmon, Einat, Meiner, Vardiella, Sella, Tamar, Hamburger, Tamar, Peretz, Tamar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8443779/ https://www.ncbi.nlm.nih.gov/pubmed/34540661 http://dx.doi.org/10.3389/fonc.2021.683656 |
Ejemplares similares
-
Breast Cancer with Low Recurrence Score on Oncotype DX(©): Interplay Between Early Recurrence, Lobular Histology and BRCA Mutation
por: Zarbiv, Yonaton, et al.
Publicado: (2022) -
Potential Refinement of Recurrence Score by pSTAT3 Status
por: Grinshpun, Albert, et al.
Publicado: (2022) -
Effects of the single nucleotide polymorphism at MDM2 309 on breast cancer patients with/without BRCA1/2 mutations
por: Nechushtan, Hovav, et al.
Publicado: (2009) -
Splicing Factor Transcript Abundance in Saliva as a Diagnostic Tool for Breast Cancer
por: Bentata, Mercedes, et al.
Publicado: (2020) -
Clinical course and outcome of patients with high-level microsatellite instability cancers in a real-life setting: a retrospective analysis
por: Halpern, Naama, et al.
Publicado: (2017)